Nano-Cap Equillium Shares Fall After Patchy Hair Loss Study Data
Equillium released topline data from its Phase 2 study of EQ101 in adult patients with alopecia areata, a disease that results in patchy hair loss.
What’s Going On With Ford Motor Stock On Tuesday?
Ford's electric vehicle sales for May jumped 64.7% year over year to 8,966 units, while sales for hybrid vehicles rose 64.5% year over year to 17,631 units.
Mid-Cap Firm Annexon’s Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study
Annexon reports positive Phase 3 trial results for ANX005 in Guillain-Barré syndrome, showing significant improvements in disability, muscle strength, and ventilation duration.
Philip Morris International Raises 2024 Earnings Outlook, Expects Growth Despite Currency Impact
Philip Morris International revised its 2024 full-year for Currency Only diluted earnings per share forecast on Tuesday.
Bristol Myers Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients
Opdivo plus Yervoy combo shows significant survival benefits and higher response rates vs. lenvatinib/sorafenib in HCC.
Roaring Kitty’s GameStop Options Could Be Worth $54M, But Cashing Out Might Be Tricky: ‘Everybody’s Hyper Aware Of This Now’
The size of the position and the attention on GameStop could make selling the options or taking delivery of the underlying shares problematic.
What’s Going On With Chinese EV Maker Li Auto Shares Tuesday?
Li Auto reportedly implements significant sales and delivery process changes amid ongoing team restructuring, aiming to align goals and enhance sales performance.
What’s Going On With MicroStrategy Stock Today?
MicroStrategy shares hold steady in today's trading despite news of a $40 million tax fraud lawsuit settlement involving CEO Michael Saylor.
What’s Going On With Viking Therapeutics Stock On Tuesday?
Viking Therapeutics reports promising 52-week data from its Phase 2b VOYAGE study on VK2809 for NASH.
Fidelity Pushes For ETF Listing And Maintenance Fees After Threatening To Charge Investors If No Agreement Is Reached
Fidelity's move is seen as an attempt to generate new industry revenues amid a shift from mutual funds to generally cheaper and more tax-efficient ETFs.